65FR37790A Proposed Data Collections Submitted for Public Comment and Recommendations
robop...@us.govnews.org
Posting-number: Volume 65, Issue 117, Page 37790A
[Federal Register: June 16, 2000 (Volume 65, Number 117)]
[Notices]
[Page 37790-37791]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16jn00-65]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-00-40]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Seleda Perryman, CDC-
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Project
Exposure to Aerosolized Brevetoxins During Red Tide Events--New--
National Center for Environmental Health (NCEH). Gymnodinium breve is
the marine dinoflagellate responsible for extensive blooms (called red
tides) that form in the gulf of Mexico. G. breve produces potent
toxins, called brevetoxins, that have been responsible for killing
millions of fish and other marine organisms. The biochemical activity
of brevetoxins is not completely understood and there is very little
information regarding human health effects from environmental
exposures, such as inhaling brevetoxin that has been aerosolized and
swept onto the coast by offshore winds. The National Center for
Environmental Health (NCEH), Centers for Disease Control and Prevention
(CDC) is planning to recruit 100 people who work along the coast of
Florida and who potentially will be occupationally exposed to
aerosolized red tide toxins some time during the year following
recruitment.
NCEH plans on administering a base-line respiratory health
questionnaire and conducting pre- and post-shift pulmonary function
tests during a time when there is no red tide reported near the area.
When a red tide develops, we plan to administer a symptom survey and
conduct pulmonary function testing (PFT) on a group of study
participants who are working in the area where the red tide is near
shore, and on a control group of study participants who are not working
in an area where the red tide is near shore (i.e., are not exposed to
the red tide). We will then compare (1) symptom reports before and
during the red tide and (2) the changes in baseline PFT values during
the work shift (differences between pre- and post-shift PFT results
without exposure to red tide) with the changes in PFT values during the
work shift when individuals are exposed to red tide. In addition, we
plan to assist in collecting biological specimens (inflammatory cells
from nose and throat swabs) to assess whether they can be used to
verify exposure and to demonstrate a biological effect (i.e.,
inflammatory response) from exposure to red tide. There are no costs to
respondents.
----------------------------------------------------------------------------------------------------------------
No. of Average burden
Respondents No. of responses per per response Total burden
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Pulmonary History Questionnaire................. 100 1 20/60 33
Symptom Questionnaire........................... 100 20 5/60 167
Nasal and throat swabs.......................... 100 20 5/60 167
Pulmonary Function Tests........................ 100 20 20/60 667
---------------------------------------------------------------
Total....................................... .............. .............. .............. 1034
----------------------------------------------------------------------------------------------------------------
[[Page 37791]]
Dated: June 12, 2000.
Kathy Cahill,
Associate Director for Policy, Planning, and Evaluation, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 00-15253 Filed 6-15-00; 8:45 am]
BILLING CODE 4163-18-P